chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got Covid from someone who got vaccinated; I got Covid from someone who got vaccinated; This is a spontaneous report from a non contactable consumer. An unspecified age and gender patient received an unknown dose of BNT162B2 (COMIRNATY) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. The patient stated: "I was watching a video from (name)today. They were questioning 2 college athletes who said they don't want to take the jab. They preferred their own immunity versus taking the vaccine. They don't want any side effects from the vaccine. Indian doctors took ivermectin and they did not get sick.  So they did not pull out your Pfizer vaccine but instead pulled out ivermectin. I don't trust your medicine. My system is strong enough to beat it by itself. You did not get it the way you said you got it.  You did not make it. Moderna gave you their concoction and you just backed it off to 30 mcg. It should not exist because it is damaging to aquatic life. It is highly poisonous and dangerous. People take it and they pee it out and it kills fish and they die. You have put down hydrochloroquine, zinc, you won't give nobody vitamin D or C, you stick them in a room for 7 days in a hospital when they are feeling bad. Why would you want to kill somebody. Think about that. I got Covid from someone who got vaccinated (caller did not provide name of vaccination or manufacturer). I recovered in 4 days". The outcome of event s was recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nursing assistant concerning her 11 year old daughter with no allergies and a history of viral meningitis at the age of 15 months who in 1995 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. In 2002, the pt developed chickenpox. The pt was covered from head to toe with lesions. The pt was seen at the clinic by a physician and treated with acetaminophen (TYLENOL), diphenhydramine hydrochloride (BENADRYL) and oatmeal baths. One and a half weeks later, the chickenpox subsided and the pt recovered. It was noted that prior to this, the pt had been exposed to many children with chickenpox and had no symptoms. A product quality complaint was not involved. Follow up information from a medical office indicated the pt had no pre-existing allergies, birth defects or medical conditions and was vaccinated on 26Feb1999 SC in the right arm with the first dose of varicella virus vaccine live. Illness at the time of vaccination included herpetic gingivitis and an upper respiratory infection. On 18Jun2002 at 15:11, the pt had an episode of varicella. Additional information is not expected.
Patient felt a rush go to her chest and felt mild shortness of breath. She then felt a very dry mouth and tingling around her mouth. No rash. No N/V/D. No hypoxia. No wheezing. Patient required no interventions aside from 500 cc bolus because she felt dehydrated and oral rehydration.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 41 years for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Moderna (Dose 1, single, Vaccine lot unknown reason=Not available/provided to reporter at the time of report completion), administration date: Mar2021, for COVID-19 immunization; Moderna (Dose 2, single, Vaccine lot unknown reason=Not available/provided to reporter at the time of report completion), administration date: Apr2021, for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Clinical course: Patient experienced Rebound COVID on 26May2022 which was not recovered. Other medication in 2weeks was unknown. Anti-viral details were provided as, COVID 19 Treatment with Paxlovid from 15May2022 to 20May2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received vaccine and began to feel "not right".  She had nausea, some dizziness and felt "not right" in the head.  She sat with head close to knees with cool/damp paper towel on back of neck.  As she started to feel better she sat upright.  She sat this way for several minutes.  She stated she was feeling better and wanted to try standing.  She was able to stand without issue.
1/6 1:30 vaccination Later that evening, I had extreme HA. I had 2-3 aura migraines, a day or 2 later.  Insomnia.  *still experiencing insomnia and anxiety
Patient presenting with complaint of itchiness to head, back, neck, face. Provider assessed patient ordered Benadryl PO. Provider noted could be allergies no rash, swelling, Anxiety related as patient felt better 2 min after Benadryl. Patient monitored for 30 min sent home and advised to go to ER if symptoms worsen.  Vital signs BP: 142/82 HR: 75 RR:16 02:98%
My first 3 doses were Moderna. On 04/23/2022, I developed severe chills, some nasal congestion/post nasal drip and sore throat. Later that week, I developed chest congestion and coughing. I thought these symptoms were allergy/asthma related. I was tested for COVID on 04/30/2022 (requirement to return home from abroad) which was positive. I saw a doctor through the local health system. He listened to my chest, knew I had asthma issues, and due to my chest congestion prescribed antiviral medication (Molnupiravir). I had symptoms for several days and I took another rapid test on 05/04/2022 which came back negative. I took another test on 05/05/2022 for the purposes of returning home, which was negative, so I returned home on 05/06/2022.
fever of 102, chills nausea, lack of appetite. fatigue .over  36 hours/ arm pain lasted for 4days/// fever of 100 at 4am then fever of 102.2 at 5am, took medicine but temperature was  consistent. struggle to get out of bed, only for restroom- also I was covid positive on 12-8-20 . Was recovered for approximately 2 weeks before I received the vaccine.  Was told I could and should receive the vaccine.
Can't move around without her walker; Dizzy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Can't move around without her walker), DIZZINESS (Dizzy) and NAUSEA (Nauseous) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A211A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (Dizzy) and NAUSEA (Nauseous). On an unknown date, the patient experienced GAIT DISTURBANCE (Can't move around without her walker). At the time of the report, GAIT DISTURBANCE (Can't move around without her walker), DIZZINESS (Dizzy) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Concomitant medications are not provided by the reporter. No treatment drugs are not provided by reporter.
Red area size of golf ball-swollen lump 1/2 size of baseball-to L arm. Treatment-Ibuprofen, ice.
VACCINE EXPOSURE DURING PREGNANCY; MARGINAL CORD INSERTION; HEADACHE; FATIGUE; SORE ARM; VACCINE EXPOSURE BEFORE PREGNANCY; This solicited pregnancy report received from a consumer concerned a 26-year-old female of unspecified ethnic origin. The patient was enrolled in a non-company sponsored study. The patient's weight was 83.45 kilograms, and height was not reported. The patient was gravida 2 and para 1. The patient's concurrent conditions included: multigravida (She had a previous pregnancy that resulted in a live baby), anxiety, polycystic ovary syndrome, no alcohol use, and no tobacco use. The patient had taken the prenatal vitamins. She had no recreational drug use. The pregnancy was still ongoing. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: JUN-2021) dose was not reported, 1 total, administered on 03-APR-2021 for prophylactic vaccination. Concomitant medications included metformin, and sertraline hydrochloride for unknown indications. On APR-2021, the patient experienced vaccine exposure before pregnancy and on an unspecified date, the patient experienced vaccine exposure during pregnancy. The date of the patient's last menstrual period was 05-APR-2021 and expected delivery date was 10-JAN-2022. On 03-APR-2021, she had sore arm. On 04-APR-2021, she had headache and fatigue. On 07-SEP-2021, she underwent prenatal ultrasound (Ultrasound scan) which showed marginal cord insertion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 05-APR-2021, was recovering from headache, and fatigue, and the outcome of marginal cord insertion, vaccine exposure before pregnancy and vaccine exposure during pregnancy was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and marginal cord insertion, vaccine exposure before pregnancy, and vaccine exposure during pregnancy was not related, and between covid-19 vaccine ad26.cov2.s, and sore arm, headache, and fatigue was related.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211056779-covid-19 vaccine ad26.cov2.s-Marginal cord insertion. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY  20211056779-covid-19 vaccine ad26.cov2.s- Vaccine exposure after pregnancy, Vaccine exposure before pregnancy. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Adverse events include about 7-10 days of mild redness, itchiness and pain at the site and surrounding area of injection. I treated with over the counter hydrocortisone cream (1x daily). This mild adverse reaction only occurred after the first dose and resolved by around day 10. I had no symptoms or reactions to the second dose (systemic or locally). I had previously contracted COVID-19 in March 2020.
Headache; Body was warm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Body was warm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and PYREXIA (Body was warm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) and PYREXIA (Body was warm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) Test result came (Positive) on 26-JAN-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 09-JUN-2015 the patient was inadvertently vaccinated with an expired dose of VARIVAX (Merck), subcutaneous, expiration date 27-MAR-2015, (dose number, anatomical location and lot number were unspecified). No adverse effects reported. Additional information has been requested.
it turned into a solid red circle/couple of little raised, red bumps around the injection site/red/by Sunday it was just a pink outline; started to develop a rash at the injection site; couple of little raised, red bumps around the injection site/raised/flat/an inch around the injection site/faded quite a bit; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE RASH (started to develop a rash at the injection site), VACCINATION SITE MASS (couple of little raised, red bumps around the injection site/raised/flat/an inch around the injection site/faded quite a bit) and VACCINATION SITE ERYTHEMA (it turned into a solid red circle/couple of little raised, red bumps around the injection site/red/by Sunday it was just a pink outline) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1416B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Jun-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2022, the patient experienced VACCINATION SITE RASH (started to develop a rash at the injection site) and VACCINATION SITE MASS (couple of little raised, red bumps around the injection site/raised/flat/an inch around the injection site/faded quite a bit). On 09-Jul-2022, the patient experienced VACCINATION SITE ERYTHEMA (it turned into a solid red circle/couple of little raised, red bumps around the injection site/red/by Sunday it was just a pink outline). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 11-Jul-2022, VACCINATION SITE RASH (started to develop a rash at the injection site), VACCINATION SITE MASS (couple of little raised, red bumps around the injection site/raised/flat/an inch around the injection site/faded quite a bit) and VACCINATION SITE ERYTHEMA (it turned into a solid red circle/couple of little raised, red bumps around the injection site/red/by Sunday it was just a pink outline) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was provided by the reporter. It was reported  that it lasted for 2-3 days and he did not experience any systemic symptoms after receiving his 1st dose.
Child received Pediarix, MMR and Varicella on 9/13/05. Mom reported to clinic on 9/27 with c/o developing a mild rash on chest on 9/16 or no later than 9/17. The rash increased and then know est on stomach and back, then mildly on arm, face and legs. Examined by Dr 9/27/05. Rash probably secondary to MMR vaccine. Cannot r/o other viral exanthem.
Patient is reporting mild body aches and headaches, she also reports fatigue along with nausea and loose bowels.
Headache & Diarrhea diarrhea bad - three time within 4 hrs of vaccine
17 days subsequent to receiving one dose of varicella virus vaccine live the pt developed one large vesicle above the eyebrow. The next day he developed swollen glands that were tender to the touch. By 4 days later he had 13 vesicular lesions on his face, a major headache, and body aches. The pt sought unspecified medical attention. No further information is available.
Lost appetite. I can still be hungry but no food sounds good and I eat about 1/3 of what I used to and I'm full /borderline uncomfortablly full.
sore arm; under 18 years old; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment medication was not reported. The concomitant medication was not reported.
Severe stomach pain, Fainting episodes, Seizure like activity, Mobility loss from time to time, Ovarian cysts.
This spontaneous report was received from a registered nurse regarding a 5 year old patient of unknown gender. There was no information on pertinent medical history and drug reactions or allergies. On 22-APR-2015, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously (dose, product lot#, expiry date not reported) instead of a dose of (Merck) VARIVAX. No adverse effects was reported. There was no product quality complaint involved. The outcome of the events was unknown. Additional information has been requested.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Phenergan with an associated reaction of pain, Phenergan with an associated reaction of swelling and Phenergan with an associated reaction of nerve injury (Nerve damage in right shoulder that has resolved). Concurrent medical conditions included drug allergy (injected in righ deltoid). Concomitant products included Herpes zoster (Shingrix), ascorbic acid (Vitamin C) and zinc.   On 11th October 2019, the patient received the 2nd dose of Shingrix. On 11th October 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. Rechallenge with Shingrix was positive. In October 2019, the outcome of the pain in arm was resolved with sequelae.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: in 2000, the patient had an allergic reaction to a phenergan injection that was injected in the righ deltoid. It caused soreness and swelling and resulted in nerve damage in the right shoulder that has resolved The patient received 2nd dose of Shingrix vaccine in left arm and experienced sore arm on the same day which was lasted for 2 to 3 days. The patient received echincea as concomitant. The reporter consented to follow up. This is 1 of the 3 cases, reported by same reporter.
About 5 minutes after vaccine patient slowly fell to the ground and lost consciousness. His body slightly twitched but did not observe eye rolling into back of head, or incontinence. Patient stated prior to receiving vaccine he began feeling lightheaded and has a phobia of needles. Has a history of seizures when an adolescent and last seizure was when he was 19 years old.
Patient reported stroke like symptoms. Now sees a neurologist for further care. We were made aware on 07/31/2016.
Shingles; Pain; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2020) for prophylaxis.   Concomitant products included prednisone and azathioprine.   On 22nd October 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 25th October 2019, 3 days after receiving Shingrix, the patient experienced shingles and pain. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles and pain were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingrix.  Additional details were provided as follows: The reported batch number K9M59 was updated to K9M5N as per sales data sheet. On tuesday, the patient received Shingrix on left arm. On the reporting date, the patient experienced shingles and pain. On the reporting date, the patient went to the doctor today and was confirmed with shingles. The patient was prescribed valtrex for shingles.  No further details were provided.
Pt developed rash at injection site that lasted for approximately 3 days. Approximately one week later pt experienced overwhelming pain in upper right arm. Diagnosed as bursitis and prescribed Celebrex. Treated with pain medications.
Information has been received from a physician concerning a female patient who on 25-FEB-2008 was vaccinated with the third dose of GARDASIL. No lot number was provided. The physician reported that the patient had a positive lab test for lupus about six months (August 2008) after the date of the third dose of GARDASIL. Physician does not wish to be contacted. The patient sought unspecified medical attention. Upon internal review, lupus was determined to be an other important medical event. No further information is available.
Was healthy prior to vaccine.  This was the 2nd dose, the first shot had no side effects.  After the 2nd shot, patient started to feel ill on the day after.  Due to  him fighting sinus infections he went to Dr.  and he was prescribed antibiotics.  His main symptoms in his lungs seemed to be getting worse.  Back to the  dr.  Chest x-ray showed no infection.  A week later after finishing antibiotics still not  feeling well, got a CT of his lungs.  Double pneumonia.   5 weeks  later after intense antibiotics, steroids, and breathing treatments, and a lung washing , patient is just now feeling somewhat normal.   After looking on the internet and speaking with others that have had a similar reaction to the 2nd shingle shot, I feel it that these  types of side effects are very serious and patients, and medical Personel  need to made aware of the possibility?s
Day after vaccine pt started getting red spots on his skin that were itchy and bled once scrated. pt did not think they were hives.
PATIENT GOT FIRST DOSE OF MODERNA ON 03/11/21 AND PASSED AWAY ON 03/28/2021
Fatigue and headache that evening at 8pm. Next day same. A week later after 9 nine days diagnosis Covid. 17 and 18 Sep - headache and congestion. On 19 urgent care and got tested. I deteriorated with fatigue and headache. By Wednesday, I had diarrhea and got 23Sep monoclonal infusion. After or 24Sep - my Covid symptoms were gone, Crohn's systems flared up again. 24Sep stared the steroids.
About four months after second vaccine, I noticed swelling of my left breast and swelling of lymph nodes in left armpit. I had pain and tenderness in left breast for over a month, and decided to go see my OBGYN to get checked. She did an exam and sent me for a breast MRI, which came back normal. Since then, my lymph nodes in armpit are not swollen anymore, but still have tenderness and swelling in left breast. This started around the first of September and now seems to be getting better.
1/17 headache, fever, fatigue 1/18 headache, sore throat, fever, fatigue 1/19 diarrhea, headache, sore throat, fever, fatigue